3.63
price up icon1.68%   0.06
after-market Dopo l'orario di chiusura: 3.63
loading
Precedente Chiudi:
$3.57
Aprire:
$3.6142
Volume 24 ore:
931
Relative Volume:
0.01
Capitalizzazione di mercato:
$5.60M
Reddito:
$2.54M
Utile/perdita netta:
$-4.13M
Rapporto P/E:
-1.32
EPS:
-2.75
Flusso di cassa netto:
$-4.11M
1 W Prestazione:
+0.00%
1M Prestazione:
+32.48%
6M Prestazione:
-15.58%
1 anno Prestazione:
-14.59%
Intervallo 1D:
Value
$3.6142
$3.6999
Intervallo di 1 settimana:
Value
$3.4473
$3.95
Portata 52W:
Value
$2.20
$5.2683

Xenetic Biosciences Inc Stock (XBIO) Company Profile

Name
Nome
Xenetic Biosciences Inc
Name
Telefono
781-778-7720
Name
Indirizzo
945 CONCORD ST., FRAMINGHAM, MA
Name
Dipendente
2
Name
Cinguettio
@XeneticBio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
XBIO's Discussions on Twitter

Confronta XBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XBIO
Xenetic Biosciences Inc
3.63 5.51M 2.54M -4.13M -4.11M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-01-08 Iniziato Maxim Group Buy

Xenetic Biosciences Inc Borsa (XBIO) Ultime notizie

pulisher
Jul 23, 2025

Xenetic Biosciences Inc. Stock Analysis and ForecastHigh-yield market plays - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform - Great Falls Tribune

Jul 23, 2025
pulisher
Jul 23, 2025

Xenetic expands DNase-I collaboration with Scripps Research By Investing.com - Investing.com South Africa

Jul 23, 2025
pulisher
Jul 23, 2025

Revolutionary Cancer Treatment: Xenetic and Scripps Advance DNase-CAR-T Therapy for Lymphoma and Leukemia - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Xenetic Biosciences Inc. stockRobust investment performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Xenetic Biosciences Inc. stock priceExceptional market positioning - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Xenetic Biosciences Inc. a good long term investmentConsistently exceptional gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Why Xenetic Biosciences Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Xenetic Biosciences Inc. stock price move sharplyFree Exclusive Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Xenetic Biosciences Inc. stock performs during market volatilityOptimized Return Investment Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Xenetic Biosciences (NASDAQ:XBIO) Shares Down 8% – What’s Next? - Defense World

Jul 15, 2025
pulisher
Jul 12, 2025

Head to Head Comparison: Xenetic Biosciences (NASDAQ:XBIO) versus Vaxart (NASDAQ:VXRT) - Defense World

Jul 12, 2025
pulisher
Jul 09, 2025

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic C - The Holland Sentinel

Jul 09, 2025
pulisher
Jul 09, 2025

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration - Great Falls Tribune

Jul 09, 2025
pulisher
Jul 08, 2025

North Shore Uranium Engages Investing News Network - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

LQR House Announces Strategic Marketing Cooperation with Montauk Distilling Co. for Cinnamon Flavored Rum - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

Groundbreaking Pancreatic Cancer Trial Launches: DNase I Combined With FOLFIRINOX in Advanced Cases - Stock Titan

Jul 08, 2025
pulisher
Jul 07, 2025

Unusual Machines Inc. Promotes Stacy Wright to Executive Vice President of Revenue as Company Scales U.S. Footprint and Prepares for Accelerated Growth - Great Falls Tribune

Jul 07, 2025
pulisher
Jun 25, 2025

Xenetic Biosciences’ 13.5% Surge: What’s Driving the Unexplained Rally? - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Pre-market Movers: NKTR, INM, IBIO, IBO... - RTTNews

Jun 24, 2025
pulisher
Jun 12, 2025

Why Did Cyclacel Pharmaceuticals Inc. (CYCC) Soar 13.92%? - AInvest

Jun 12, 2025
pulisher
Jun 10, 2025

Xenetic Biosciences Reports Improved Q1 2025 Results - TipRanks

Jun 10, 2025

Xenetic Biosciences Inc Azioni (XBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):